Director Dealing

RNS Number : 5311X

Port Erin Biopharma Investments Ltd

08 February 2013

 



Port Erin Biopharma Investments Limited

 ("Port Erin" or the "Company")

Director's Dealing

Port Erin, the AIM listed company focused on investing in the biotechnology and biopharmaceutical sectors, was informed that the Chairman, Jim Mellon, purchased 744,000 Ordinary Shares at an average price of 8.23 pence per share on 6^th February 2013. The Company was further informed that Galloway Limited had acquired 1,000,000 Ordinary Shares at a price of 6.00 pence per share on 5^th February, 2013.

Galloway Limited is wholly owned by a trust in which Jim Mellon, Chairman of the Company, has a life tenancy. Denham Eke, a Director of the Company, is a Director of Galloway Limited.

Following this transaction, the total Ordinary Shares in which Jim Mellon has a beneficial interest is 6,760,000 representing 20.5% of the issued ordinary share capital of the Company.

Enquiries:

Port Erin Biopharma Investments Limited
Denham Eke	([phone]
Libertas Capital Corporate Finance Limited
Sandy Jamieson	([phone]
Rivington Street Corporate Finance Limited
John Levinson	([phone]

 

END

 

 

RDSQVLFBXLFFBBE